2019
Annual Advances in Cancer Prevention Lecture:
The Precancer Genome Atlas (PCGA) and Immune Interception
Scott M. Lippman, M.D., is director of Moores Cancer Center at UC San Diego Health, professor of Medicine at UC San Diego School of Medicine, senior associate dean and associate vice chancellor for Cancer Research and Care and holds the Chugai Pharmaceutical Chair in Cancer. He is also an adjunct professor at the Salk Institute, the Sanford-Burnham Medical Research Institute and MD Anderson Cancer Center.
Dr. Lippman has been recognized in every major “Top Doctor" listing including U.S. News & World Report. He has received numerous awards, including the American Cancer Society of Clinical Oncology (ASCO) Award, the American Association for Cancer Research (AACR) Award and the ASCO Statesman Award.
Dr. Lippman brings more than 25 years of experience as principal investigator of translational research involving investigator-initiated clinical trials. He has participated in the national leadership of clinical/translational research planning and development within the National Cancer Institute Cooperative Group setting and currently serves on the National Cancer Institute’s Clinical Trials and Translational Research Advisory Committee. He is also a member of the Board of Directors for the AACR, the Association of American Cancer Institutes and the National Comprehensive Cancer Network and has served on the FDA Oncologic Drugs Advisory Committee. Dr. Lippman is an elected member of the prestigious Association of American Physicians.
He has authored more than 300 publications in high-impact journals, including The New England Journal of Medicine, the Journal of the American Medical Association, the Proceedings of the National Academy of Sciences and The Lancet, and chapters in major medical textbooks.
Before joining UC San Diego Health, he was chair of the Department of Thoracic/Head and Neck Medical Oncology at MD Anderson Cancer Center.
Dr. Lippman completed fellowships in hematology and medical oncology at Stanford University and the University of Arizona. He completed an internship and residency training in internal medicine at The Johns Hopkins Hospital and Harbor-UCLA Medical Center. He received his medical degree from The Johns Hopkins University School of Medicine. He is board-certified in internal medicine, hematology and medical oncology.